欧洲戒烟辅助产品市场预测至 2028 年 - COVID-19 影响和按产品(尼古丁替代疗法、药物、电子烟等)和最终用户(医院药房、在线渠道、零售药房和其他最终用户)进行的区域分析

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 117    |    Report Code: TIPRE00024109    |    Category: Life Sciences

Europe Smoking Cessation Aids Market

市场介绍

戒烟可以降低患癌症和其他严重健康问题的风险。有些产品含有尼古丁作为活性成分,而另一些则不含。咨询、行为治疗、药物和含尼古丁产品,如尼古丁贴片、口香糖、含片、吸入器和鼻喷雾剂,可用于帮助人们戒烟。它们受到 FDA 药物评估和研究中心的监管,确保产品安全有效,并且其益处超过任何已知的相关风险。

 

市场概况和动态

欧洲戒烟辅助市场预计将进入美国到 2028 年,将从 2021 年的 70.8948 亿美元增至 186.398 亿美元;预计 2021 年至 2028 年复合年增长率为 14.8%。推动该市场增长的关键因素是减少吸烟和烟草依赖的活动数量不断增加以及世界各地推出新的戒烟辅助工具。然而,尼古丁替代疗法的开发成本高昂,可能会在一定程度上抑制未来几年的市场增长。

世界各地的政府和非政府组织正在挺身而出,推出尼古丁替代疗法。开展宣传活动并采取措施遏制因吸烟和烟草消费引起的疾病。采取这些措施是为了减轻世界各国因吸烟造成的经济和健康负担。例如,每年 5 月 31 日,世界卫生组织及其全球合作伙伴都会庆祝世界无烟日 (WNTD),以传播有关烟草和二手烟暴露的有害和致命影响的教育和认识。这一天采取的举措主要旨在阻止任何形式的烟草消费,并教育人们了解有助于戒烟的辅助工具的可用性。全球、国家和地区层面都组织了反吸烟运动的发起。各国政府提高了烟草卷烟和雪茄的消费税和税收,以降低其承受能力,从而降低普通民众的消费量。此外,许多政府已在许可销售渠道下将电子烟作为戒烟辅助工具的使用合法化,以防止人们选择传统香烟。因此,政府以及非营利组织和非政府组织为促进戒烟辅助工具的使用和减少吸烟人口数量而做出的越来越大的努力促进了市场的增长。随着戒烟辅助市场参与者推出新的创新疗法,药物和烟草滥用治疗行业的竞争力逐年增强。此外,地方和区域层面的市场参与者正在推出无尼古丁电子烟和电子烟等医疗设备。因此,不断推出创新的戒烟辅助工具将成为未来几年戒烟辅助工具市场的流行趋势。

欧洲地区受到的影响很大,因为COVID-19 大流行的爆发。根据世界卫生组织的说法,他们一直在不断评估新的研究,新的研究表明,烟草和尼古丁的使用之间存在正相关关系,有助于 COVID-19 患者康复。对于增加感染 COVID-19 的风险,吸烟是导致潜在健康状况的主要原因。然而,目前没有足够的信息来证实烟草或尼古丁在预防或治疗 COVID-19 方面之间存在任何联系。因此,COVID-19大流行对欧洲地区戒烟辅助市场的影响较小。

 

主要细分市场

根据产品,欧洲戒烟辅助市场分为尼古丁替代疗法、药物、电子烟等。 2021年,电子烟细分市场可能会占据最大的市场份额,并预计在未来几年以最快的速度增长。

根据最终用户,欧洲戒烟辅助工具市场分为医院药房、在线渠道、零售药房和其他最终用户。零售药店细分市场可能会在 2021 年占据最大的市场份额,而在线渠道细分市场预计在预测期内的市场复合年增长率最高。

 

主要来源和上市公司

与本欧洲戒烟辅助市场报告相关的一些主要和次要来源包括法国国家预防和健康教育研究所 (INPES)、欧洲制药工业和协会联合会 (EFPIA) 以及不列颠哥伦比亚自然疗法协会 (INPES)。 BCNA)。

 

购买报告的理由

  • 根据欧洲戒烟辅助品市场的详细趋势分析确定潜在投资领域 /span>未来几年。
  • 深入了解推动不同成瘾疗法需求的潜在因素 span>在支出最高的国家/地区进行细分,并确定每个国家/地区提供的机会。
  • 加强您对需求驱动因素、行业趋势、以及最新的技术发展等。
  • 确定推动欧洲戒烟辅助市场的主要渠道 /span>清晰地描绘未来的机会,这将有助于分析,从而增加收入。
  • 通过关注不同国家正在进行的项目来引导资源 欧洲戒烟辅助市场

 < /span>

欧洲戒烟辅助产品市场细分

按产品< /strong>

  • 尼古丁替代疗法
  • 药物
  • 电子烟
  • 其他

 

最终用户

  • 医院药房
  • 在线渠道
  • 零售药店
  • 其他最终用户

< strong>按国家/地区

  • 英国
  • 德国
  • 法国
  • 意大利
  • 西班牙
  • 欧洲其他地区

公司简介

  • 辉瑞公司
  • 葛兰素史克公司
  • 博士。雷迪实验室
  • 强生服务公司
  • 西普拉公司
  • Perrigo Company plc
  • Bausch Health Companies Inc.
  • Glenmark
  • < /ul>

     

     

     

    Europe Smoking Cessation Aids Strategic Insights

    Strategic insights for Europe Smoking Cessation Aids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-smoking-cessation-aids-market-strategic-framework.webp
    Get more information on this report

    Europe Smoking Cessation Aids Report Scope

    Report Attribute Details
    Market size in 2021 US$ 7,089.48 Million
    Market Size by 2028 US$ 18,639.80 Million
    Global CAGR (2021 - 2028) 14.8%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 尼古丁替代疗法
    • 药物
    • 电子香烟
    By 最终用户
    • 医院药房
    • 在线渠道
    • 零售药房
    • 其他最终用户
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Dr. Reddys Laboratories
  • Johnson and Johnson Services, Inc.
  • Cipla Inc.
  • Perrigo Company plc
  • Bausch Health Companies Inc.
  • Glenmark
  • Get more information on this report

    Europe Smoking Cessation Aids Regional Insights

    The regional scope of Europe Smoking Cessation Aids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-smoking-cessation-aids-market-geography.webp
    Get more information on this report

The List of Companies - Europe Smoking Cessation Aids Market

  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Dr. Reddy's Laboratories
  • Johnson and Johnson Services, Inc.
  • Cipla Inc.
  • Perrigo Company plc
  • Bausch Health Companies Inc.
  • Glenmark

 

Frequently Asked Questions
How big is the Europe Smoking Cessation Aids Market?

The Europe Smoking Cessation Aids Market is valued at US$ 7,089.48 Million in 2021, it is projected to reach US$ 18,639.80 Million by 2028.

What is the CAGR for Europe Smoking Cessation Aids Market by (2021 - 2028)?

As per our report Europe Smoking Cessation Aids Market, the market size is valued at US$ 7,089.48 Million in 2021, projecting it to reach US$ 18,639.80 Million by 2028. This translates to a CAGR of approximately 14.8% during the forecast period.

What segments are covered in this report?

The Europe Smoking Cessation Aids Market report typically cover these key segments-

  • 产品 (尼古丁替代疗法, 药物, 电子香烟)
  • 最终用户 (医院药房, 在线渠道, 零售药房, 其他最终用户)
  • What is the historic period, base year, and forecast period taken for Europe Smoking Cessation Aids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Smoking Cessation Aids Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Smoking Cessation Aids Market?

    The Europe Smoking Cessation Aids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Dr. Reddys Laboratories
  • Johnson and Johnson Services, Inc.
  • Cipla Inc.
  • Perrigo Company plc
  • Bausch Health Companies Inc.
  • Glenmark
  • Who should buy this report?

    The Europe Smoking Cessation Aids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Smoking Cessation Aids Market value chain can benefit from the information contained in a comprehensive market report.